Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 158.90
-1.30 (-0.81%)
Jun 19, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 211 billion as of June 18, 2026. Its market cap has decreased by -23.06% in one year.
Market Cap
211.00B
Enterprise Value
254.19B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
158.90
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 211.00B, a decrease of -6.94%. That is a compound annual growth rate of -1.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 211.00B | -7.73% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 402.32B |
| Ajanta Pharma | 382.81B |
| Gland Pharma | 362.30B |
| Emcure Pharmaceuticals | 336.71B |
| Wockhardt | 326.79B |
| Eris Lifesciences | 200.70B |
| NATCO Pharma | 159.23B |
| Cohance Lifesciences | 155.26B |